$121.00M Market Cap.
CLYM Market Cap. (MRY)
CLYM Shares Outstanding (MRY)
CLYM Assets (MRY)
Total Assets
$217.19M
Total Liabilities
$5.31M
Total Investments
$125.30M
CLYM Income (MRY)
Revenue
$0
Net Income
-$73.90M
Operating Expense
$82.02M
CLYM Cash Flow (MRY)
CF Operations
-$15.56M
CF Investing
-$121.09M
CF Financing
$130.73M
CLYM Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | - | - | 0% | - |
CLYM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $217,187,000 (96.60%) | $110,469,000 (-18.17%) | $134,992,000 (-22.08%) | $173,241,000 (603.35%) |
Assets Current | $154,872,000 (40.47%) | $110,255,000 (-17.96%) | $134,393,000 (-9.35%) | $148,252,000 (573.93%) |
Assets Non-Current | $62,315,000 (29019.16%) | $214,000 (-64.27%) | $599,000 (-97.60%) | $24,989,000 (849.07%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $211,881,000 (96.92%) | $107,599,000 (-16.41%) | $128,715,000 (-23.02%) | $167,203,000 (769.27%) |
Property Plant & Equipment Net | $490,000 (146.23%) | $199,000 (-57.75%) | $471,000 (0%) | $0 (0%) |
Cash & Equivalents | $87,229,000 (-6.32%) | $93,112,000 (113.63%) | $43,585,000 (-7.11%) | $46,922,000 (129.03%) |
Accumulated Other Comprehensive Income | $23,000 (1250.00%) | -$2,000 (99.44%) | -$358,000 (-191.06%) | -$123,000 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $125,300,000 (815.53%) | $13,686,000 (-82.89%) | $79,981,000 (-30.13%) | $114,477,000 (0%) |
Investments Current | $63,690,000 (365.37%) | $13,686,000 (-82.89%) | $79,981,000 (-10.69%) | $89,558,000 (0%) |
Investments Non-Current | $61,610,000 (0%) | $0 (0%) | $0 (0%) | $24,919,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $705,000 (968.18%) | $66,000 (-91.20%) | $750,000 (-46.58%) | $1,404,000 (8.58%) |
Accumulated Retained Earnings (Deficit) | -$229,876,000 (-47.38%) | -$155,979,000 (-29.06%) | -$120,860,000 (-59.83%) | -$75,616,000 (-168.75%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $532,000 (52.44%) | $349,000 (-27.29%) | $480,000 (0%) | $0 (0%) |
Debt Current | $157,000 (-52.99%) | $334,000 (11.33%) | $300,000 (0%) | $0 (0%) |
Debt Non-Current | $375,000 (2400.00%) | $15,000 (-91.67%) | $180,000 (0%) | $0 (0%) |
Total Liabilities | $5,306,000 (84.88%) | $2,870,000 (-54.28%) | $6,277,000 (3.96%) | $6,038,000 (97.13%) |
Liabilities Current | $4,931,000 (74.06%) | $2,833,000 (-53.53%) | $6,097,000 (1.09%) | $6,031,000 (96.90%) |
Liabilities Non-Current | $375,000 (913.51%) | $37,000 (-79.44%) | $180,000 (2471.43%) | $7,000 (0%) |
CLYM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $16,025,000 (-35.55%) | $24,864,000 (31.41%) | $18,921,000 (53.21%) | $12,350,000 (409.28%) |
Research & Development Expense | $14,336,000 (-6.98%) | $15,411,000 (-41.21%) | $26,214,000 (12.40%) | $23,322,000 (149.65%) |
Operating Expenses | $82,020,000 (103.65%) | $40,275,000 (-10.77%) | $45,135,000 (26.53%) | $35,672,000 (70.48%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$73,897,000 (-110.42%) | -$35,119,000 (22.38%) | -$45,244,000 (4.71%) | -$47,480,000 (-129.73%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$73,897,000 (-110.42%) | -$35,119,000 (22.38%) | -$45,244,000 (4.71%) | -$47,480,000 (-129.73%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $4,548,000 (99.04%) |
Net Income Common Stock | -$73,897,000 (-110.42%) | -$35,119,000 (22.38%) | -$45,244,000 (13.04%) | -$52,028,000 (-126.67%) |
Weighted Average Shares | $48,163,301 (78.47%) | $26,987,122 (2.57%) | $26,311,554 (114.60%) | $12,260,551 (460.40%) |
Weighted Average Shares Diluted | $48,163,301 (78.47%) | $26,987,122 (2.57%) | $26,311,554 (114.60%) | $12,260,551 (460.40%) |
Earning Before Interest & Taxes (EBIT) | -$73,897,000 (-110.42%) | -$35,119,000 (22.38%) | -$45,244,000 (4.71%) | -$47,480,000 (-129.73%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$82,020,000 (-103.65%) | -$40,275,000 (10.77%) | -$45,135,000 (-26.53%) | -$35,672,000 (-70.48%) |
CLYM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$121,092,000 (-275.54%) | $68,981,000 (100.29%) | $34,440,000 (129.96%) | -$114,970,000 (-1523.25%) |
Net Cash Flow from Financing | $130,729,000 (15444.47%) | $841,000 (0%) | $0 (0%) | $177,232,000 (3498.62%) |
Net Cash Flow from Operations | -$15,562,000 (24.45%) | -$20,599,000 (44.88%) | -$37,369,000 (-3.60%) | -$36,072,000 (-155.87%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$5,883,000 (-111.88%) | $49,527,000 (1584.18%) | -$3,337,000 (-112.62%) | $26,435,000 (3691.71%) |
Net Cash Flow - Business Acquisitions and Disposals | -$9,645,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$111,447,000 (-261.56%) | $68,981,000 (100.29%) | $34,440,000 (129.96%) | -$114,970,000 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $130,729,000 (15444.47%) | $841,000 (0%) | $0 (0%) | $83,293,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $42,000 (-86.18%) | $304,000 (174.51%) | -$408,000 (-266.53%) | $245,000 (-31.75%) |
Share Based Compensation | $5,557,000 (-56.61%) | $12,806,000 (83.18%) | $6,991,000 (87.08%) | $3,737,000 (428.57%) |
Depreciation Amortization & Accretion | $220,000 (-45.68%) | $405,000 (-8.58%) | $443,000 (0%) | $0 (0%) |
CLYM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -38.90% (-23.89%) | -31.40% (2.79%) | -32.30% (61.22%) | -83.30% (-155.42%) |
Return on Average Assets (ROAA) | -38.20% (-25.66%) | -30.40% (1.30%) | -30.80% (23.57%) | -40.30% (59.58%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -148.50% (-152.98%) | -58.70% (-36.19%) | -43.10% (45.92%) | -79.70% (99.09%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -1.18 (43.38%) | -2.08 (2.67%) | -2.13 (13.50%) | -2.47 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.57 (-17.49%) | 0.69 (-8.71%) | 0.76 (-54.36%) | 1.66 |
Debt to Equity Ratio (D/E) | 0.03 (-7.41%) | 0.03 (-44.90%) | 0.05 (36.11%) | 0.04 (129.27%) |
Earnings Per Share (EPS) | -1.53 (-17.69%) | -1.3 (24.42%) | -1.72 (59.43%) | -4.24 (59.58%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.32 (57.67%) | -0.76 (46.27%) | -1.42 (51.73%) | -2.94 (54.35%) |
Book Value Per Share (BVPS) | 4.4 (10.33%) | 3.99 (-18.50%) | 4.89 (-64.13%) | 13.64 (219.42%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.51 (10.16%) | 4.09 (-20.23%) | 5.13 (-63.69%) | 14.13 (25.51%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | -1 (80.00%) | -5 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.34 (167.39%) | -0.51 (63.52%) | -1.39 (69.36%) | -4.53 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 31.41 (-19.30%) | 38.92 (76.56%) | 22.04 (-10.33%) | 24.58 (242.27%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$15,562,000 (24.45%) | -$20,599,000 (44.88%) | -$37,369,000 (-3.60%) | -$36,072,000 (-155.87%) |
Enterprise Value (EV) | -$25,114,232 (-243.08%) | $17,552,193 (-71.75%) | $62,130,389 (-71.09%) | $214,939,145 |
Earnings Before Tax (EBT) | -$73,897,000 (-110.42%) | -$35,119,000 (22.38%) | -$45,244,000 (4.71%) | -$47,480,000 (-129.73%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$73,677,000 (-112.24%) | -$34,714,000 (22.52%) | -$44,801,000 (5.64%) | -$47,480,000 (-129.73%) |
Invested Capital | $125,559,000 (744.21%) | $14,873,000 (-82.66%) | $85,790,000 (-28.68%) | $120,288,000 (11027.47%) |
Working Capital | $149,941,000 (39.58%) | $107,422,000 (-16.27%) | $128,296,000 (-9.79%) | $142,221,000 (651.10%) |
Tangible Asset Value | $217,187,000 (96.60%) | $110,469,000 (-18.17%) | $134,992,000 (-22.08%) | $173,241,000 (603.35%) |
Market Capitalization | $121,002,768 (62.54%) | $74,446,193 (-23.65%) | $97,503,389 (-64.90%) | $277,758,145 |
Average Equity | $189,829,500 (69.98%) | $111,675,500 (-20.30%) | $140,112,750 (124.33%) | $62,459,250 (508.97%) |
Average Assets | $193,684,500 (67.85%) | $115,390,750 (-21.55%) | $147,093,500 (13.85%) | $129,201,250 (461.43%) |
Invested Capital Average | $49,758,250 (-16.79%) | $59,795,000 (-43.05%) | $105,002,750 (76.28%) | $59,566,750 (25247.55%) |
Shares | 67,223,760 (143.81%) | 27,572,664 (3.78%) | 26,567,681 (0.05%) | 26,554,316 (6.40%) |
